IBG vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 24, 2026

IBG

40.4
AI Score
VS
NIVF Wins

NIVF

51.2
AI Score

Investment Advisor Scores

IBG

40score
Recommendation
HOLD

NIVF

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBG NIVF Winner
Revenue 2.93M 4.73M NIVF
Net Income -2.57M 9.88M NIVF
Gross Margin 76.1% 20.2% IBG
Net Margin -87.7% 209.0% NIVF
Operating Income -3.20M -10.73M IBG
ROE -98.2% 37.1% NIVF
ROA -51.9% 30.2% NIVF
Total Assets 4.96M 32.72M NIVF
Cash 619,944 758,621 NIVF
Current Ratio 1.14 3.12 NIVF
Free Cash Flow -1.58M -11.06M IBG

Relative Price Performance (Last 90 Days)

IBG 1M: -11.9% · 3M: -17.6% NIVF 1M: +41.7% · 3M: -61.8%

Current Technical Phase

IBG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 43

RSI (14): 43.5 · Price: $0.89

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.4%), weak momentum, RSI 31

RSI (14): 31.3 · Price: $0.65

Fundamentals Snapshot

Metric IBG NIVF
Market Cap
Forward P/E -17.8 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.4% 0.1%
Gross Margin 0.8% 0.2%
Operating Margin -1.2% -3.5%
EPS -7.75 109.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.